Market Cap 29.23M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 208,647
Avg Vol 171,420
Day's Range N/A - N/A
Shares Out 8.70M
Stochastic %K 19%
Beta 1.14
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
valueinvestor1998
valueinvestor1998 Aug. 5 at 9:35 PM
$BCTX The 16.6-month median OS is encouraging but highly uncertain: it came from a very small, selected Phase 2 subgroup, not a randomized comparison against physician’s-choice therapy. The broader formulation analysis showed HR 0.58 with a 95% CI of 0.20–1.40 so it was not statistically significant. Be careful with your investment and confidence here.
0 · Reply
Aye_Sir
Aye_Sir Aug. 5 at 9:21 PM
$BCTX hammertime
0 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 8:28 PM
$BCTX this set up has all the ingredients for double digits runner (swing multi day )
0 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 7:11 PM
1 · Reply
valueinvestor1998
valueinvestor1998 Aug. 5 at 7:07 PM
$BCTX everyone please be careful. Too many clueless people pumping the stock on this board. Their previous results never showed statistical significance. KPTI just got wiped out because of a similar situation. If you want to invest here, keep in mind this is a lottery ticket. These guys have been an old major cancer, conferences, and many investors saw their work. There’s a reason they are trading so low.
3 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 6:58 PM
$YXT from 3s to 25 💪🏾🤔 $BCTX 3s now with news and it will go soon .. 100%+ runner AH tonight or pre market tomorrow $INLF $SPCX $JLHL
0 · Reply
ZacksResearch
ZacksResearch Aug. 5 at 6:15 PM
$BCTX just cleared a major FDA hurdle — is this the next catalyst to watch? 🚀 ✅ The FDA issued a Study May Proceed letter for Bria-PROS+, clearing it for clinical evaluation in prostate cancer. 🧬 BriaCell says its personalized, off-the-shelf immunotherapy is designed to activate multiple components of the immune system, with preclinical data showing activation of T-cells, dendritic cells, and NK cells. Find more on BCTX here👉 https://www.zacks.com/stock/quote/BCTX?cid=sm-stocktwits-0-quote_overview-oc-39135&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39135
0 · Reply
MikeTechnician
MikeTechnician Aug. 5 at 5:21 PM
$BCTX adds another near-term catalyst: FDA clearance to initiate clinical evaluation of Bria-PROS+ in prostate cancer. News: https://bit.ly/4pX8Grz
0 · Reply
JediGreen
JediGreen Aug. 5 at 3:43 PM
0 · Reply
JediGreen
JediGreen Aug. 5 at 3:42 PM
$BCTX Renmark Virtual Non-Deal Roadshow: TSX - BCT | NASDAQ - BCTX (ID 2997) https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-06-25-11-00-00/index.html
0 · Reply
Latest News on BCTX
BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site

2026-07-16T13:27:49.000Z - 20 days ago

BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site


BriaCell announces Odette Cancer Centre joins Bria-IMT trial

2026-07-16T11:40:48.000Z - 20 days ago

BriaCell announces Odette Cancer Centre joins Bria-IMT trial


BriaCell enters MoU with Uneedle for microneedle technology

2026-06-25T11:45:30.000Z - 5 weeks ago

BriaCell enters MoU with Uneedle for microneedle technology


BriaCell Therapeutics Announces Closing of Offering

Tue, 02 Jun 2026 16:05:00 -0400 - 2 months ago

BriaCell Therapeutics Announces Closing of Offering


BriaCell Presents Positive Clinical Data at ASCO 2026

Mon, 01 Jun 2026 07:30:00 -0400 - 2 months ago

BriaCell Presents Positive Clinical Data at ASCO 2026


BriaCell Therapeutics Announces Pricing of Offering

Sun, 31 May 2026 19:59:00 -0400 - 2 months ago

BriaCell Therapeutics Announces Pricing of Offering


BriaCell announces data from Bria-IMT at ASCO 2026

2026-05-22T11:49:02.000Z - 2 months ago

BriaCell announces data from Bria-IMT at ASCO 2026


BriaCell adds Penn Medicine as Phase 3 breast cancer study site

2026-05-13T14:41:55.000Z - 3 months ago

BriaCell adds Penn Medicine as Phase 3 breast cancer study site


BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Tue, 12 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients


BriaCell receives FDA clearance to initiate Bria-BRES+ trial

2026-05-07T04:03:56.000Z - 3 months ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial


BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Mon, 27 Apr 2026 07:30:00 -0400 - 3 months ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026


BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T13:28:43.000Z - 3 months ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting


BriaCell presents anti-cancer activity of Bria-OTS

2026-04-21T11:54:23.000Z - 3 months ago

BriaCell presents anti-cancer activity of Bria-OTS


BriaCell to present four posters at the 2026 AACR

2026-03-18T11:42:55.000Z - 5 months ago

BriaCell to present four posters at the 2026 AACR


BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 5 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting


BriaCell Therapeutics trading resumes

2026-01-13T14:41:11.000Z - 7 months ago

BriaCell Therapeutics trading resumes


BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T14:35:29.000Z - 7 months ago

BriaCell Therapeutics trading halted, volatility trading pause


BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 10 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025


valueinvestor1998
valueinvestor1998 Aug. 5 at 9:35 PM
$BCTX The 16.6-month median OS is encouraging but highly uncertain: it came from a very small, selected Phase 2 subgroup, not a randomized comparison against physician’s-choice therapy. The broader formulation analysis showed HR 0.58 with a 95% CI of 0.20–1.40 so it was not statistically significant. Be careful with your investment and confidence here.
0 · Reply
Aye_Sir
Aye_Sir Aug. 5 at 9:21 PM
$BCTX hammertime
0 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 8:28 PM
$BCTX this set up has all the ingredients for double digits runner (swing multi day )
0 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 7:11 PM
1 · Reply
valueinvestor1998
valueinvestor1998 Aug. 5 at 7:07 PM
$BCTX everyone please be careful. Too many clueless people pumping the stock on this board. Their previous results never showed statistical significance. KPTI just got wiped out because of a similar situation. If you want to invest here, keep in mind this is a lottery ticket. These guys have been an old major cancer, conferences, and many investors saw their work. There’s a reason they are trading so low.
3 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 6:58 PM
$YXT from 3s to 25 💪🏾🤔 $BCTX 3s now with news and it will go soon .. 100%+ runner AH tonight or pre market tomorrow $INLF $SPCX $JLHL
0 · Reply
ZacksResearch
ZacksResearch Aug. 5 at 6:15 PM
$BCTX just cleared a major FDA hurdle — is this the next catalyst to watch? 🚀 ✅ The FDA issued a Study May Proceed letter for Bria-PROS+, clearing it for clinical evaluation in prostate cancer. 🧬 BriaCell says its personalized, off-the-shelf immunotherapy is designed to activate multiple components of the immune system, with preclinical data showing activation of T-cells, dendritic cells, and NK cells. Find more on BCTX here👉 https://www.zacks.com/stock/quote/BCTX?cid=sm-stocktwits-0-quote_overview-oc-39135&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39135
0 · Reply
MikeTechnician
MikeTechnician Aug. 5 at 5:21 PM
$BCTX adds another near-term catalyst: FDA clearance to initiate clinical evaluation of Bria-PROS+ in prostate cancer. News: https://bit.ly/4pX8Grz
0 · Reply
JediGreen
JediGreen Aug. 5 at 3:43 PM
0 · Reply
JediGreen
JediGreen Aug. 5 at 3:42 PM
$BCTX Renmark Virtual Non-Deal Roadshow: TSX - BCT | NASDAQ - BCTX (ID 2997) https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-06-25-11-00-00/index.html
0 · Reply
OatesTheGoat
OatesTheGoat Aug. 5 at 3:21 PM
$BCTX Over 3.6 watch for a move to $4
0 · Reply
MikeTechnician
MikeTechnician Aug. 5 at 2:35 PM
FDA says "Study May Proceed" for BriaCell's Bria-PROS+ prostate cancer program. Clinical testing is next. $BCTX Regulatory milestone ✅ News: https://bit.ly/4pX8Grz #Biotech #CancerImmunotherapy #ProstateCancer #HealthcareStocks
0 · Reply
Goodstockday
Goodstockday Aug. 5 at 1:32 PM
$BCTX New company slogan: “BriaCell - We save both breasts and balls!”
0 · Reply
BCTX20bMC
BCTX20bMC Aug. 5 at 1:26 PM
$BCTX The cry babies are broken records during the week…Dilution & RS is all they have…Then they fill out their signs & protest on weekends.
2 · Reply
Merlintrader
Merlintrader Aug. 5 at 1:22 PM
$BCTX FDA clears the Bria-PROS+ IND, allowing a Phase 1/2a prostate-cancer study to begin https://www.merlintrader.com/briacell-therapeutics-stock-hub/
0 · Reply
MikeTechnician
MikeTechnician Aug. 5 at 1:16 PM
FDA says "Study May Proceed" for BriaCell's Bria-PROS+ prostate cancer program. Clinical testing is next. $BCTX Regulatory milestone ✅ News: https://bit.ly/4pX8Grz #Biotech #CancerImmunotherapy #ProstateCancer #HealthcareStocks
0 · Reply
BCTX20bMC
BCTX20bMC Aug. 5 at 1:15 PM
$BCTX again…and again…and again….for the thick skulls with pea brains. They have enough $ to get them to the p3 readout. After the positive p3 news they will then prob raise more funds when the SP is 25+…Patience.
1 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 12:46 PM
$BCTX news out and not sure why it’s not $5+ yet 🧐 I bought some herd mid 3s $AMIX went crazy yesterday $YXT going now $CISS still strong 💪🏾 $DBGI 💪🏾
0 · Reply
Kirubin
Kirubin Aug. 5 at 12:40 PM
$BCTX Where do you think the money will come from🥶🥶 ! offering machine. Expect plenty more coming your way!
1 · Reply
prismmarketview
prismmarketview Aug. 5 at 12:37 PM
$BCTX FDA clearance is in for BriaCell’s Bria-PROS prostate cancer study, clearing the way for clinical evaluation of its cell-based immunotherapy candidate. https://prismmarketview.com/briacell-gets-fda-clearance-to-launch-bria-pros-study-in-prostate-cancer/
0 · Reply
BioTerror
BioTerror Aug. 5 at 12:16 PM
$BCTX when news drops on a low float and no ones paying attention. I'm loading... expecting a delayed reaction here ⏳💣
0 · Reply
KJolive
KJolive Aug. 5 at 12:13 PM
$BCTX in for 5k shares
0 · Reply